Stay updated on HBM4003 & Toripalimab in Advanced NEN Clinical Trial
Sign up to get notified when there's something new on the HBM4003 & Toripalimab in Advanced NEN Clinical Trial page.

Latest updates to the HBM4003 & Toripalimab in Advanced NEN Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new Revision: v3.3.3 was added; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the footer.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedThe record history shows an added revision (v3.3.2) and removal of an older revision (v3.2.0), which are administrative updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check48 days agoChange DetectedThe top government funding/operating status notice has been removed from the page, removing the banner about potential delays and updates. The study record content remains unchanged.SummaryDifference0.8%

- Check56 days agoChange DetectedVersion 3 (2025-04-24) updates the record with a new Recruitment Status and related Study Status, including changes to Study Identification, Conditions, Design, Arms and Interventions, Eligibility, and Contacts/Locations.SummaryDifference0.1%

- Check91 days agoChange DetectedMajor update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.SummaryDifference13%

- Check98 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0, indicating a new release with updated revision metadata.SummaryDifference0.3%

Stay in the know with updates to HBM4003 & Toripalimab in Advanced NEN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HBM4003 & Toripalimab in Advanced NEN Clinical Trial page.